“Rapid advances in gene-editing technology have a transformative potential to help cure disease and feed the world, but scientists must assure that the tools are not used for unethical purposes, new UC Berkeley Nobel laureate Jennifer Doudna told reporters today.
“Following this morning’s announcement that she had won the 2020 Nobel Prize in Chemistry, Doudna detailed the promise of the CRISPR-cas9 technology at a Berkeley press conference, held remotely during the coronavirus pandemic and livestreamed for a global audience.
“She hailed the collaboration of her colleagues, both at Berkeley and internationally, for the work that won the world’s highest honor in science.
“Her research began, and has continued, “with the vision of bringing genome editing to bear on problems facing humanity, whether they be in biomedicine or in agriculture,” Doudna said.”
Read more at Berkeley
